Key Takeaways UnitedHealth reaffirmed its 2025 EPS guidance despite dilution from the Amedisys deal.Analysts cut UNH earnings estimates, projecting EPS to fall even as revenue climbs.UNH faces rising medical loss ratios, regulatory probes and a steep share price drop.UnitedHealth Group Incorporated (UNH) is set to reaffirm its 2025 adjusted EPS outlook in upcoming meetings with investors and analysts, even as the recent Amedisys acquisition is expected to be “modestly dilutive” to earnings because of financ ...